Skip to Content
Merck
CN

2,4-disubstituted pyrimidines: a novel class of KDR kinase inhibitors.

Bioorganic & medicinal chemistry letters (2003-05-06)
Peter J Manley, Adrienne E Balitza, Mark T Bilodeau, Kathleen E Coll, George D Hartman, Rosemary C McFall, Keith W Rickert, Leonard D Rodman, Kenneth A Thomas
ABSTRACT

2,4-Disubstituted pyrimidines were synthesized as a novel class of KDR kinase inhibitors. Evaluation of the SAR of the screening lead compound 1 (KDR IC(50)=105 nM, Cell IC(50)=8% inhibition at 500 nM) led to the potent 3,5-dimethylaniline derivative 2d (KDR IC(50)=6 nM, cell IC(50)=19 nM).

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
4-Chloro-2-methylthiopyrimidine, 98%